Skip to main content
TipRanks
Go Ultimate75% OFF

Leidos Holdings (S6IA) AI Stock Analysis

1 Followers
CH:S6IA

Leidos Holdings

(BX Swiss:S6IA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong cash generationReliable conversion of earnings into cash strengthens Leidos’ ability to fund investment, support dividends and repurchases, and reduce reliance on external financing. The scale of cash generation also provides flexibility to pursue organic growth and strategic opportunities through the next several quarters.
Negative Factors
Health segment and VBA uncertaintyThe VBA transition creates an ongoing source of revenue and margin uncertainty in Health, with the full-quarter impact expected in the fourth quarter. Until the recompete is resolved, work-share outcomes could materially affect the segment’s contribution and consolidated growth profile.

Leidos Holdings Business Overview & Revenue Model

Company Description

Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the Unit...

Leidos Holdings Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|Next Earnings Date:Feb 16, 2027
Earnings Call SentimentPositive

The call was predominantly positive, supported by 4% revenue growth, 19% EPS growth, a 13.9% adjusted EBITDA margin, $476 million of quarterly free cash flow, improving book-to-bill, backlog growth and strong momentum in Defense, Homeland, Energy, cyber and AI. However, the Health segment's VBA-related contraction, uncertainty around the VBA recompete, expected fourth-quarter growth moderation and the statement that 2027 will not be a bottom-line growth year were meaningful concerns. Overall, the breadth of operational and pipeline strengths significantly outweighed the disclosed challenges.

Positive Updates

Strong Third-Quarter Financial Performance
Third-quarter revenue grew 4% to $4.63 billion, including 1% organic growth. Adjusted EBITDA was $644 million, with a 13.9% margin, up 10 basis points sequentially and year-over-year. Non-GAAP diluted EPS increased 19% year-over-year to $3.62.

Negative Updates

Health Segment Contraction From VBA Changes
Health revenue contracted because of the previously disclosed changes to the VBA disability examination contract. Health margins declined, although the decrease was less than expected, and the company expects a full-quarter impact from the contract changes in the fourth quarter.

Company Guidance

For 2026, Leidos maintained adjusted EBITDA guidance in the mid-13s, with the guidance assuming that the government is operating under a continuing resolution through the end of the year, diluted share count at 126 million and the non-GAAP effective tax rate around 20%; Q4 revenues are expected to be near Q3 levels, Q4 Health segment margins are expected to be in the high teens, operating cash flow guidance was effectively raised by $100 million, and the new narrowed EPS range is up around $0.37 on an adjusted basis at the midpoint. Q4 is viewed as a reasonable jumping off point for 2027, although 2027 is not a bottom line growth year; Defense has a real possibility to be a double-digit grower, Energy is expected to be a double-digit grower, and the cyber portfolio has the ability to be a double-digit grower, while Energy has a path to double-digit revenue growth and mid- to high teens margin.

Leidos Holdings Risk Analysis

Leidos Holdings disclosed 2 risk factors in its most recent earnings report. Leidos Holdings reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Leidos Holdings Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

CH:S6IA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ACNACN84Outperform$129.19B16.0026.77%3.02%6.47%11.19%
CACICACI72Outperform$13.45B24.7012.37%―10.12%7.58%
SAICSAIC71Outperform$6.01B16.6125.89%1.03%-0.78%3.90%
IBMIBM68Neutral$211.59B18.8132.95%3.02%6.83%39.80%
PSNPSN67Neutral$5.48B37.645.58%―-2.67%-61.86%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%

* Technology Sector Average

Performance Comparison

-50%0%50%ACNCACIIBMSAICPSNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:S6IA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ACNAccenture Plc218.58-24.80-10.19%
CACICaci International605.325.380.90%
IBMInternational Business Machines Corporation223.88-65.62-22.67%
SAICScience Applications International Corp.143.3359.2970.54%
PSNParsons Corp51.95-29.73-36.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.